Colorectal cancer screening: Clinical Practice Guidelines in oncology™ Review uri icon

Overview

MeSH Major

  • Adenomatous Polyposis Coli
  • Colorectal Neoplasms
  • Colorectal Neoplasms, Hereditary Nonpolyposis
  • Genetic Testing
  • Mass Screening

abstract

  • Colorectal cancer is the third most frequently diagnosed cancer in men and women in the United States. An estimated 104,950 new cases of colon cancer and 40,340 new cases of rectal cancer will occur in the United States in 2005. During the same year, an estimated 56,290 people will die from colon and rectal cancer. Because patients with localized colon cancer have a 90% 5-year survival rate, screening is a critical and particularly effective procedure for colorectal cancer prevention. Screening options include colonoscopy; combined fecal occult blood test (FOBT) and sigmoidoscopy; sigmoidoscopy alone; or double-contrast barium enema. © Journal of the National Comprehensive Cancer Network.

publication date

  • April 2006

Research

keywords

  • Review

Identity

Language

  • eng

PubMed ID

  • 16569391

Additional Document Info

start page

  • 384

end page

  • 420

volume

  • 4

number

  • 4